TrialThe Lancet. Oncology2018

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.

Theodore W Laetsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.